Honglei Kang

1.6k total citations · 2 hit papers
40 papers, 973 citations indexed

About

Honglei Kang is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Honglei Kang has authored 40 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Honglei Kang's work include Bone Metabolism and Diseases (12 papers), Bone Tissue Engineering Materials (8 papers) and Spine and Intervertebral Disc Pathology (6 papers). Honglei Kang is often cited by papers focused on Bone Metabolism and Diseases (12 papers), Bone Tissue Engineering Materials (8 papers) and Spine and Intervertebral Disc Pathology (6 papers). Honglei Kang collaborates with scholars based in China, Japan and Qatar. Honglei Kang's co-authors include Feng Li, Yimin Dong, Renpeng Peng, Pengju Wang, Hanfeng Guan, Shian Hu, Kehan Song, Weizhong Ding, Qian Guo and Meipeng Zhu and has published in prestigious journals such as Cell Metabolism, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Honglei Kang

37 papers receiving 965 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019

2022 235 citations Weizhong Ding, Shian Hu et al. Spine profile →
A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis

2024 48 citations Yimin Dong, Honglei Kang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Honglei Kang China	18	280	261	228	166	110	40	973
Donghua Huang China	20	404 1.4×	235 0.9×	229 1.0×	247 1.5×	91 0.8×	44	1.0k
Renpeng Peng China	13	241 0.9×	210 0.8×	141 0.6×	82 0.5×	73 0.7×	23	678
Frank Vandenabeele Belgium	20	391 1.4×	480 1.8×	387 1.7×	91 0.5×	121 1.1×	55	1.7k
Matthew J. Beckman United States	18	381 1.4×	270 1.0×	183 0.8×	199 1.2×	58 0.5×	35	1.2k
Xiaobin Guo China	22	158 0.6×	518 2.0×	270 1.2×	113 0.7×	111 1.0×	50	1.2k
Jun Ge China	22	289 1.0×	236 0.9×	200 0.9×	247 1.5×	29 0.3×	57	1.1k
Xiexing Wu China	17	291 1.0×	312 1.2×	246 1.1×	198 1.2×	74 0.7×	34	901
Ximing Xu China	19	485 1.7×	211 0.8×	469 2.1×	122 0.7×	50 0.5×	85	1.0k
Kuibo Zhang China	18	309 1.1×	180 0.7×	220 1.0×	163 1.0×	37 0.3×	29	886
Haishan Wu China	20	82 0.3×	234 0.9×	379 1.7×	111 0.7×	185 1.7×	60	1.3k

Countries citing papers authored by Honglei Kang

Since Specialization

Citations

This map shows the geographic impact of Honglei Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Kang more than expected).

Fields of papers citing papers by Honglei Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglei Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Kang. The network helps show where Honglei Kang may publish in the future.

Co-authorship network of co-authors of Honglei Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Honglei Kang. A scholar is included among the top collaborators of Honglei Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglei Kang. Honglei Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Meng, Honglei Kang, Yimin Dong, et al.. (2025). Methyl-CpG-binding domain 2 mitigates osteoarthritis through Steap3 promoter methylation and chondrocyte ferroptosis regulation. Experimental & Molecular Medicine. 57(11). 2629–2642.

Liu, Jiawei, Jinjin Zhu, Takashi Goto, et al.. (2025). Modulation of bone homeostasis by dual drug-loaded premixed magnesium tri-magnesium phosphate bone cement for the treatment of osteoporotic vertebral compression fractures. Bioactive Materials. 54. 631–647. 1 indexed citations

Peng, Renpeng, Yimin Dong, Meng Zheng, et al.. (2024). IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism. Cell Death and Disease. 15(2). 111–111. 20 indexed citations

Liu, Huiyong, et al.. (2024). The miR-19a/Cylindromatosis Axis Regulates Pituitary Adenoma Bone Invasion by Promoting Osteoclast Differentiation. Cancers. 16(2). 302–302. 1 indexed citations

Peng, Renpeng, Chao Song, Shuangquan Gou, et al.. (2024). Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor. Pharmacological Research. 202. 107121–107121. 16 indexed citations

Wang, Sibo, Qian Ren, Yi Dai, et al.. (2023). α-Mangostin Exhibits a Therapeutic Effect on Spinal Cystic Echinococcosis by Affecting Glutamine Metabolism. Antimicrobial Agents and Chemotherapy. 67(6). e0009823–e0009823. 2 indexed citations

Liu, Jiawei, Honglei Kang, Wenying Wei, et al.. (2023). Bioactive calcium and mangnesium phosphate bone adhesive for enhanced vascularization and bone regeneration. Journal of Material Science and Technology. 164. 246–257. 6 indexed citations

Kang, Honglei, et al.. (2023). 3D Printed Photothermal Scaffold Sandwiching Bacteria Inside and Outside Improves The Infected Microenvironment and Repairs Bone Defects. Advanced Healthcare Materials. 13(6). e2302879–e2302879. 29 indexed citations

Dong, Yimin, Yayun Zhang, Kehan Song, et al.. (2022). What was the Epidemiology and Global Burden of Disease of Hip Fractures From 1990 to 2019? Results From and Additional Analysis of the Global Burden of Disease Study 2019. Clinical Orthopaedics and Related Research. 481(6). 1209–1220. 68 indexed citations

10.

Peng, Renpeng, Yimin Dong, Honglei Kang, et al.. (2022). Identification of Genes with Altered Methylation in Osteoclast Differentiation and Its Roles in Osteoporosis. DNA and Cell Biology. 41(6). 575–589. 5 indexed citations

11.

Ding, Weizhong, Shian Hu, Pengju Wang, et al.. (2022). Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019. Spine. 47(21). 1532–1540. 235 indexed citations breakdown →

12.

Dong, Yimin, Kehan Song, Pengju Wang, et al.. (2022). Blocking the cytohesin-2/ARF1 axis by SecinH3 ameliorates osteoclast-induced bone loss via attenuating JNK-mediated IRE1 endoribonuclease activity. Pharmacological Research. 185. 106513–106513. 12 indexed citations

13.

Kang, Honglei, Yimin Dong, Haiyang Liu, et al.. (2022). Titania-Nanotube-Coated Titanium Substrates Promote Osteogenesis and Suppress Osteoclastogenesis via Integrin ανβ3. ACS Applied Bio Materials. 5(12). 5832–5843. 3 indexed citations

14.

Liu, Fan, Honglei Kang, Zhiwei Liu, et al.. (2021). 3D Printed Multi-Functional Scaffolds Based on Poly(ε-Caprolactone) and Hydroxyapatite Composites. Nanomaterials. 11(9). 2456–2456. 19 indexed citations

15.

Dong, Yimin, Linka Xie, Honglei Kang, et al.. (2021). A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma. Spine. 46(22). E1192–E1201. 4 indexed citations

16.

Guo, Qian, Honglei Kang, Jia Wang, et al.. (2020). Inhibition of ACLY Leads to Suppression of Osteoclast Differentiation and Function Via Regulation of Histone Acetylation. Journal of Bone and Mineral Research. 36(10). 2065–2080. 41 indexed citations

17.

Zhang, Zheng, Qian Xu, Chao Song, et al.. (2019). Serum- and Glucocorticoid-inducible Kinase 1 is Essential for Osteoclastogenesis and Promotes Breast Cancer Bone Metastasis. Molecular Cancer Therapeutics. 19(2). 650–660. 23 indexed citations

18.

Wang, Jia, Hanfeng Guan, Hui Liu, et al.. (2019). Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss. Journal of Cellular and Molecular Medicine. 24(3). 2294–2307. 12 indexed citations

19.

Zhang, Honghua, Linwei Guo, Zheng Zhang, et al.. (2019). Co-Expression Network Analysis Identified Gene Signatures in Osteosarcoma as a Predictive Tool for Lung Metastasis and Survival. Journal of Cancer. 10(16). 3706–3716. 31 indexed citations

20.

Liu, Huiyong, Honglei Kang, Chao Song, et al.. (2018). Urolithin A Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in vivo. Frontiers in Pharmacology. 9. 1043–1043. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact